PARTNER THERAPEUTICS Trademark

Trademark Overview

On Monday, April 30, 2018, a trademark application was filed for PARTNER THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PARTNER THERAPEUTICS trademark a serial number of 87900605. The federal status of this trademark filing is REGISTERED as of Tuesday, June 1, 2021. This trademark is owned by Partner Therapeutics, Inc.. The PARTNER THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of blood disorders; pharmaceuticals for the treatment of infectious diseases; pharmaceuticals for the treatment of central nervous system disorders; pharmaceuticals for the treatment of pulmonary disorders
partner therapeutics

General Information

Serial Number87900605
Word MarkPARTNER THERAPEUTICS
Filing DateMonday, April 30, 2018
Status700 - REGISTERED
Status DateTuesday, June 1, 2021
Registration Number6373323
Registration DateTuesday, June 1, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of blood disorders; pharmaceuticals for the treatment of infectious diseases; pharmaceuticals for the treatment of central nervous system disorders; pharmaceuticals for the treatment of pulmonary disorders
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 9, 2018
Primary Code005
First Use Anywhere DateMonday, January 4, 2021
First Use In Commerce DateMonday, January 4, 2021

Trademark Owner History

Party NamePartner Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NamePartner Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NamePartner Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Tuesday, August 21, 2018NON-FINAL ACTION WRITTEN
Thursday, May 3, 2018NEW APPLICATION ENTERED
Wednesday, May 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 21, 2018ASSIGNED TO EXAMINER
Tuesday, August 21, 2018NON-FINAL ACTION E-MAILED
Tuesday, August 21, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 18, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 19, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, March 11, 2019ASSIGNED TO LIE
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 24, 2019SOU TEAS EXTENSION RECEIVED
Thursday, October 24, 2019TEAS REQUEST TO DIVIDE RECEIVED
Thursday, October 24, 2019SOU EXTENSION 1 FILED
Thursday, October 24, 2019DIVISIONAL REQUEST RECEIVED
Wednesday, November 6, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 8, 2019SOU EXTENSION 1 GRANTED
Friday, November 8, 2019DIVISIONAL PROCESSING COMPLETE
Tuesday, May 19, 2020SOU EXTENSION 2 FILED
Saturday, November 9, 2019CORRECTED NOA E-MAILED
Saturday, November 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 19, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, May 19, 2020SOU EXTENSION 2 GRANTED
Thursday, May 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 27, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, October 27, 2020SOU EXTENSION 3 FILED
Tuesday, October 27, 2020SOU EXTENSION 3 GRANTED
Thursday, October 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 23, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 20, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, April 20, 2021USE AMENDMENT FILED
Thursday, April 22, 2021STATEMENT OF USE PROCESSING COMPLETE
Saturday, April 24, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, May 12, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, February 8, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, February 8, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, February 8, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 11, 2025WITHDRAWAL OF ATTORNEY GRANTED
Tuesday, June 1, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, November 2, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 2, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 2, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 8, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, February 11, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED

Related Keywords

therapeutics partner pharmaceuticals treatment disorders nervous system pulmonary central infectious cancer blood